Travere Therapeutics, Inc. (0001438533) (Filer) — SEC 8-K Filing
HealthcareOther
Travere Therapeutics
May 11, 2026
Endospan Acquired by CryoLife | Healthcare M&A Deal
Announced
HealthcareGeorgiaOther
Deal Overview
CryoLife has acquired Endospan, a medical devices business in Georgia, for $15 million. Endospan develops and supplies medical device technologies used in clinical care, supporting CryoLife’s broader healthcare product portfolio. CryoLife acquisitions in the medical devices acquisition segment align with demand for specialty healthcare solutions across GA acquisitions. The other acquisition is a strategic acquisition with announced status and an estimated $10M–$25M deal size range, structured as a securities purchase option agreement.
Key Details
- Transaction
- CryoLife acquires Endospan
- Deal Size
- $10M – $25M
- Reported Value
- $15 million
Filed under
Powered by Tentt
Source healthcare deals in Georgia for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Related Deals
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
HealthcareOther
Pharvaris
May 11, 2026
A Cancer Driven by Ultra-Rare Mutation Gets Its First FDA-Approved Therapy
HealthcareDivestiture
Partner Therapeutics→Bizengri (bispecific antibody)
May 11, 2026
Oregon ASC to close after acquisition collapses amid state review
HealthcareOregonOther
The Surgery Center of Southern Oregon
May 11, 2026
Mobia Medical CEO eyes large market for stroke rehab
HealthcareCaliforniaOther
Mobia Medical
May 11, 2026